NYU Langone Health’s Division of Rheumatology, part of the Department of Medicine, is one of the leading rheumatology divisions in the country. Under the leadership of Jill P. Buyon, MD, division director, we pursue a tradition of excellence reflected in our tripartite mission of providing outstanding training of clinician–scientists; conducting innovative basic, translational, and clinical research; and offering the latest advances in clinical services.

News From NYU Langone Rheumatology

A recent study revealed that colchicine does not enhance knee pain, function, or synovial effusion size in knee osteoarthritis, with Jonathan Samuels, MD, associate professor and colleagues.

Natalie E. Azar, MD, clinical associate professor explained new study findings that reveal nearly 140 million people are eligible for weight loss medication, noting that “about 129 million people would be eligible to manage their weight, about 35 million to manage diabetes, and about 8.9 million people to manage heart disease.”

David Yaich, DO, clinical assistant professor, diagnosed a case of presumed mesenteric arteritis in the NYT series “Diagnosis” by Lisa Sanders.

Abhimanyu Amarnani, MD, PhD has been named the 2024 Recipient of the Gary S. Gilkeson Career Development Award from the Lupus Foundation of America. His research project seeks to elucidate how changes in gut bacteria contribute to lupus nephritis